An update on bone substitutes for spinal fusion


Creative Commons License

Miyazaki M., Tsumura H., Wang J. C. , ALANAY A.

EUROPEAN SPINE JOURNAL, vol.18, no.6, pp.783-799, 2009 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Review
  • Volume: 18 Issue: 6
  • Publication Date: 2009
  • Doi Number: 10.1007/s00586-009-0924-x
  • Title of Journal : EUROPEAN SPINE JOURNAL
  • Page Numbers: pp.783-799
  • Keywords: Bone substitutes, Spinal fusion, Demineralized bone matrix, Bone morphogenic protein, Gene therapy, LUMBAR INTERBODY FUSION, ILIAC CREST AUTOGRAFT, OP-1 PUTTY RHBMP-7, ANTERIOR CERVICAL DISKECTOMY, BETA-TRICALCIUM PHOSPHATE, INSTRUMENTED POSTEROLATERAL FUSIONS, ADOLESCENT IDIOPATHIC SCOLIOSIS, AUTOLOGOUS GROWTH-FACTORS, LENTIVIRAL GENE-THERAPY, MESENCHYMAL STEM-CELLS

Abstract

With the current advances in spinal surgery, an understanding of the precise biological mechanism of each bone substitute is necessary for inducing successful spinal fusion. In this review, the categories of bone substitutes include allografts, ceramics, demineralized bone matrix, osteoinductive factors, autogenous platelet concentrate, mesenchymal stem cells, and gene therapy. Further, clinical studies have been evaluated by their levels of evidence in order to elucidate the precise effect of the bone substitute employed and to establish clinical guidance. This article will review both clinical studies based on evidence and basic research in current advances in order to avoid as far as possible any chances of failure in the future and to understand cellular biology in novel technologies.